PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials

• Main Authors: István Baradács (Author), Brigitta Teutsch (Author), Alex Váradi (Author), Alexandra Bilá (Author), Ádám Vincze (Author), Péter Hegyi (Author), Tamás Fazekas (Author), Balázs Komoróczy (Author), Péter Nyirády (Author), Nándor Ács (Author), Ferenc Bánhidy (Author), Balázs Lintner (Author)
• Format: Book
• Published: BMC, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Ovarian cancer is the eighth leading cause of cancer-related death among women, characterized by late diagnosis and a high relapse rate. In randomized controlled trials, we aimed to evaluate the efficacy and safety of PARP inhibitors (PARPi) in treating advanced ovarian cancer. M...